• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 467562 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416946998 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416946998 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Chelsea Therapeutics International Up 10.0%, Shares Break Through Resistance (CHTP)

Published on Wed, 03/27/2013 - 10:24
By Adrienne Chilton

Chelsea Therapeutics International (NASDAQ:CHTP) is one of today's best performing low-priced stocks, up 10.0% to $2.03 on 1.8x average daily volume. Thus far today, Chelsea Therapeutics International has traded 4.3 million shares, vs. average volume of 2.4 million shares per day. The stock has outperformed the Dow (9.7% to the Dow's -0.4%) and outperformed the S&P 500 (9.7% to the S&P's -0.4%) during today's trading.

Potential upside of 127.8% exists for Chelsea Therapeutics International, based on a current level of $2.03 and analysts' average consensus price target of $4.62. The stock should discover initial support at its 50-day moving average (MA) of $1.31 and subsequent support at its 200-day MA of $1.23.

Chelsea Therapeutics International Ltd. is a biopharmaceutical company developing a pipeline of low toxicity antifolate compounds engineered to have anti-inflammatory and anti-tumor activity. The Company's lead candidate is in development as a metabolically inert treatment alternative to Methotrexate for rheumatoid arthritis, psoriasis, and other disorders.

Over the past year, Chelsea Therapeutics International has traded in a range of $0.70 to $4.21 and is now at $2.03, 190% above that low. The 200-day and 50-day moving averages have moved 0.67% higher and 4.52% higher over the past week, respectively.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Watch for Continued Gains in Shares of B...

Brinker International (NYSE:EAT) traded today at a new 52-week high of $55.78. This ne ...

Shares of Electronic Arts Have Risen Abo...

Shares of Electronic Arts (NASDAQ:EA) traded today at $44.50, breaking its 52-week high ...

Shares of Dr Pepper Snapple Rise to a Ne...

Shares of Dr Pepper Snapple (NYSE:DPS) traded today at $73.51, breaking its 52-week hig ...

Shares of Dun & Bradstreet Rise to a New...

Shares of Dun & Bradstreet (NYSE:DNB) traded today at $128.03, breaking its 52-week hig ...

Shares of Covanta Have Risen Above Previ...

Covanta (NYSE:CVA) traded today at a new 52-week high of $24.68. Approximately 1.3 mil ...

Shares of Copart Rise to a New 52-Week H...

Shares of Copart (NASDAQ:CPRT) traded at a new 52-week high today of $37.81. Approxima ...

Shares of Covidien Rise to a New 52-Week...

Shares of Covidien (NYSE:COV) traded at a new 52-week high today of $99.79. So far tod ...

Check Point Software Technologies: The W...

Shares of Check Point Software Technologies (NASDAQ:CHKP) traded at a new 52-week high ...